Perioperative Management of Antiplatelet and Anticoagulation Therapy in Vascular Surgery

Slobodan Tanaskovic, Jovan Petrovic, Milorad Sevkovic, Bojan Vucurevic, Andriana Bucic, Danica Bajcetic, Nenad Ilijevski, Petar Dabic
{"title":"Perioperative Management of Antiplatelet and Anticoagulation Therapy in Vascular Surgery","authors":"Slobodan Tanaskovic, Jovan Petrovic, Milorad Sevkovic, Bojan Vucurevic, Andriana Bucic, Danica Bajcetic, Nenad Ilijevski, Petar Dabic","doi":"10.59037/hjves.v5i2.47","DOIUrl":null,"url":null,"abstract":"Treatment of patients taking anticoagulant therapy (ACT) and antiplatelet therapy (APT) is a daily challenge for doctors of all specialities, and a special problem is the adequate care of these patients in the immediate perioperative period during vascular surgical procedures. This paper presents the current findings and recommendations on the perioperative use of ACT and APT and considerations of therapeutic modalities in frequent clinical cases of vascular patients. An overview of the most commonly used anticoagulant and antiplatelet drugs in clinical practice is also presented. Vascular surgical patients represent a population of patients in whom platelet coagulation and aggregation mechanism are dysregulated in many cases. There is still no broad consensus and unequivocal evidence that can direct the physician towards the right modality of therapy. The final decision rests with the physician, who should, based on the individual assessment of each patient, determine the risk and thus determine the modality of anticoagulant and antiplatelet therapy.","PeriodicalId":60152,"journal":{"name":"血管与腔内血管外科杂志","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"血管与腔内血管外科杂志","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59037/hjves.v5i2.47","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Treatment of patients taking anticoagulant therapy (ACT) and antiplatelet therapy (APT) is a daily challenge for doctors of all specialities, and a special problem is the adequate care of these patients in the immediate perioperative period during vascular surgical procedures. This paper presents the current findings and recommendations on the perioperative use of ACT and APT and considerations of therapeutic modalities in frequent clinical cases of vascular patients. An overview of the most commonly used anticoagulant and antiplatelet drugs in clinical practice is also presented. Vascular surgical patients represent a population of patients in whom platelet coagulation and aggregation mechanism are dysregulated in many cases. There is still no broad consensus and unequivocal evidence that can direct the physician towards the right modality of therapy. The final decision rests with the physician, who should, based on the individual assessment of each patient, determine the risk and thus determine the modality of anticoagulant and antiplatelet therapy.
血管外科抗血小板和抗凝治疗的围手术期管理
对接受抗凝治疗(ACT)和抗血小板治疗(APT)的患者的治疗是所有专科医生每天面临的挑战,其中一个特殊的问题是在血管外科手术的围手术期对这些患者进行充分的护理。本文介绍了目前的发现和建议的围手术期使用ACT和APT和考虑的治疗方式在临床上常见的病例血管患者。在临床实践中最常用的抗凝血和抗血小板药物的概述也提出。血管外科患者是血小板凝血和聚集机制在许多情况下失调的患者群体。仍然没有广泛的共识和明确的证据可以指导医生采取正确的治疗方式。最后的决定取决于医生,医生应该根据每个患者的个人评估来确定风险,从而确定抗凝血和抗血小板治疗的方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
947
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信